Satish Jindal
Fondateur chez Antolrx, Inc.
Profil
Satish Jindal is the founder of Verastem, Inc. (2010) and AnTolRx, Inc. (2015).
He holds the title of Head-Development at Verastem, Inc. in 2011 and Director at AnTolRx, Inc. in 2015.
Dr. Jindal is also the founder of NeoGenesis Pharmaceuticals, Inc., Elicio Therapeutics, Inc. (United States).
Dr. Jindal's current job(s) include being the Chief Executive Officer at Aleta Biotherapeutics, Inc. since 2024, Chairman & Manager at Koutif Therapeutics LLC, and General Partner at Advent Venture Partners LLP since 2022.
Dr. Jindal's former job(s) include being the Chief Executive Officer at Allied-Bristol Life Sciences LLC, Senior Director-Drug Discovery Group at PerSeptive Biosystems, Inc., Principal at Massachusetts Institute of Technology, Head-Research & Development at UCB Pharma, Inc., and Vice President at Schering-Plough Research Institute.
Dr. Jindal obtained a doctorate degree from Panjab University Chandigarh in 1992.
Postes actifs de Satish Jindal
| Sociétés | Poste | Début |
|---|---|---|
Antolrx, Inc.
 Antolrx, Inc. BiotechnologyHealth Technology Antolrx, Inc. operates in the healthcare industry focusing on biotechnology business. The company was founded by Mark Carthy and is headquartered in Boston, MA. | Fondateur | 01/01/2015 |
Koutif Therapeutics LLC
 Koutif Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Koutif Therapeutics LLC provides therapeutics services. The company was founded Rama K. Mallampalli and Beibei Billchen and is headquartered in Cleveland, OH. | Président | - |
Advent Venture Partners LLP
 Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Private Equity Investor | 01/01/2022 |
Aleta Biotherapeutics, Inc.
 Aleta Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aleta Biotherapeutics, Inc. engages in the immuno-oncology service that focuses on transforming cellular therapeutics. It allows broad spectrum of cancer indication to be targeted including currently intractable solid tumors. The company was founded by Paul Rennert and Roy Lobb and is headquartered in Natick, MA. | Directeur Général | 01/01/2024 |
Anciens postes connus de Satish Jindal
| Sociétés | Poste | Fin |
|---|---|---|
Elicio Therapeutics, Inc. (Old)
 Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Fondateur | - |
PerSeptive Biosystems, Inc.
 PerSeptive Biosystems, Inc. Medical SpecialtiesHealth Technology PerSeptive Biosystems developed and manufactured an integrated system for the purification, analysis, and synthesis of bio-molecules, reducing the time and cost of drug discoveries. BVP’s Chris Gabrieli invested in the company’s second round in December 1989. PerSeptive was purchased by Perkin Elmer, Inc. (NYSE: PKI) in 1998, it is a part of Applied Biosystems (NYSE: ABI), a subsidiary of Applera, Perkin Elmer’s former biotechnology division | Corporate Officer/Principal | - |
Allied-Bristol Life Sciences LLC
 Allied-Bristol Life Sciences LLC BiotechnologyHealth Technology Allied-Bristol Life Sciences LLC engages in the development of biopharmaceutical innovations. It creates a paradigm of drug discovery and incubation that benefits individuals and treatment options for health conditions. Its therapeutic area of interest are cardiovascular and genetically defined diseases, immunology, oncology, and virology. The company was founded in 2014 and is headquartered in Boston, MA. | Directeur Général | - |
UCB Pharma, Inc.
 UCB Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services UCB Pharma, Inc. provides research, development & commercialisation of pharmeceutical and biotechnology products. Its products are Keppra, Xyzal, Atarax, Lortab, Dipentum, and Tussionex. UCB Pharma develops small and large molecule treatments for a variety of diseases and ailemts. The company was founded by Emmanuel Janssen in 1928 and is headquartered in Smyrna, GA. | Directeur Technique/Scientifique/R&D | - |
| Massachusetts Institute of Technology | Corporate Officer/Principal | - |
Formation de Satish Jindal
| Panjab University Chandigarh | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| VERASTEM, INC. | Health Technology |
| Entreprise privées | 10 |
|---|---|
PerSeptive Biosystems, Inc.
PerSeptive Biosystems, Inc. Medical SpecialtiesHealth Technology PerSeptive Biosystems developed and manufactured an integrated system for the purification, analysis, and synthesis of bio-molecules, reducing the time and cost of drug discoveries. BVP’s Chris Gabrieli invested in the company’s second round in December 1989. PerSeptive was purchased by Perkin Elmer, Inc. (NYSE: PKI) in 1998, it is a part of Applied Biosystems (NYSE: ABI), a subsidiary of Applera, Perkin Elmer’s former biotechnology division | Health Technology |
NeoGenesis Pharmaceuticals, Inc.
 NeoGenesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeoGenesis Pharmaceuticals, Inc. used to discover and develop small molecule drugs. The company was founded in 1997 by Allen H. Michels and was headquartered in Cambridge, MA | Health Technology |
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Finance |
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Health Technology |
UCB Pharma, Inc.
UCB Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services UCB Pharma, Inc. provides research, development & commercialisation of pharmeceutical and biotechnology products. Its products are Keppra, Xyzal, Atarax, Lortab, Dipentum, and Tussionex. UCB Pharma develops small and large molecule treatments for a variety of diseases and ailemts. The company was founded by Emmanuel Janssen in 1928 and is headquartered in Smyrna, GA. | Commercial Services |
Schering-Plough Research Institute
 Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Health Technology |
Allied-Bristol Life Sciences LLC
Allied-Bristol Life Sciences LLC BiotechnologyHealth Technology Allied-Bristol Life Sciences LLC engages in the development of biopharmaceutical innovations. It creates a paradigm of drug discovery and incubation that benefits individuals and treatment options for health conditions. Its therapeutic area of interest are cardiovascular and genetically defined diseases, immunology, oncology, and virology. The company was founded in 2014 and is headquartered in Boston, MA. | Health Technology |
Antolrx, Inc.
Antolrx, Inc. BiotechnologyHealth Technology Antolrx, Inc. operates in the healthcare industry focusing on biotechnology business. The company was founded by Mark Carthy and is headquartered in Boston, MA. | Health Technology |
Koutif Therapeutics LLC
Koutif Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Koutif Therapeutics LLC provides therapeutics services. The company was founded Rama K. Mallampalli and Beibei Billchen and is headquartered in Cleveland, OH. | Commercial Services |
Aleta Biotherapeutics, Inc.
Aleta Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aleta Biotherapeutics, Inc. engages in the immuno-oncology service that focuses on transforming cellular therapeutics. It allows broad spectrum of cancer indication to be targeted including currently intractable solid tumors. The company was founded by Paul Rennert and Roy Lobb and is headquartered in Natick, MA. | Commercial Services |
